Cargando…
Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer
BACKGROUND: The currently-used modes of administration of immunotherapeutic agents result in their limited delivery to the lymph nodes and/or require repetitive ultrasound-guided nodal injections or microsurgical lymphatic injections, limiting their feasibility. Here, we report on the feasibility an...
Autores principales: | Radomski, Michal, Zeh, Herbert J., Edington, Howard D., Pingpank, James F., Butterfield, Lisa H., Whiteside, Theresa L., Wieckowski, Eva, Bartlett, David L., Kalinski, Pawel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835859/ https://www.ncbi.nlm.nih.gov/pubmed/27096100 http://dx.doi.org/10.1186/s40425-016-0128-y |
Ejemplares similares
-
Intralymphatic immunotherapy
por: Senti, Gabriela, et al.
Publicado: (2015) -
Intralymphatic Histiocytosis
por: Garcia-Mouronte, Emilio, et al.
Publicado: (2022) -
Locally Invasive Papillary Intralymphatic Angioendothelioma Arising Within a Lymphatic/Venous Malformation
por: Al-Refai, Reham, et al.
Publicado: (2023) -
Intralymphatic Histiocytosis: An Unusual Presentation
por: Blackwell, Timothy J., et al.
Publicado: (2021) -
DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling
por: Tal, Orna, et al.
Publicado: (2011)